PharmAthene, Inc (PIP) - NYSEMKT
  • Dec. 2, 2013, 1:53 PM
    • PharmAthene (PIP +1.6%) terminates an agreement that called for a subsidiary to merge with Theraclone in an all-stock deal.
    • PIP will pay Theraclone a $1M termination fee. (PR)
    | Dec. 2, 2013, 1:53 PM | 1 Comment
Company Description
PharmAthene, Inc. operates as a biodefense company, which is engaged in the development and commercialization of medical countermeasures against biological and chemical threats. Its biodefense candidates include Anthrax vaccines including SparVax, a second generation liquid recombinant... More
Sector: Healthcare
Industry: Biotechnology
Country: United States